UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Structure of a heparin-linked biologically active dimer of fibroblast growth factor

Nature (London), 1998-06, Vol.393 (6687), p.812-817

1998

Volltextzugriff (PDF)

FGF Binding and FGF Receptor Activation by Synthetic Heparan-Derived Di- and Trisaccharides

Science (American Association for the Advancement of Science), 1995-04, Vol.268 (5209), p.432-436

1995

Volltextzugriff (PDF)

Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells

Molecular and Cellular Biology, 1992-01, Vol.12 (1), p.240-247

1992

Volltextzugriff (PDF)

Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin

The Journal of biological chemistry, 1993-04, Vol.268 (11), p.7685-7691

1993

Volltextzugriff (PDF)

Differential effect of cell-associated heparan sulfates on the binding of keratinocyte growth factor (KGF) and acidic fibroblast growth factor to the KGF receptor

The Journal of biological chemistry, 1994-12, Vol.269 (51), p.32279-32285

1994

Volltextzugriff (PDF)

Inhibition of antigen-induced acute bronchoconstriction, airway hyperresponsiveness, and mast cell degranulation by a nonanticoagulant heparin : Comparison with a low molecular weight heparin

American journal of respiratory and critical care medicine, 1997-06, Vol.155 (6), p.1848-1855

1997

Volltextzugriff (PDF)

Importance of Size, Sulfation, and Anticoagulant Activity in the Potentiation of Acidic Fibroblast Growth Factor by Heparin

The Journal of biological chemistry, 1989-04, Vol.264 (12), p.6892-6897

1989

Volltextzugriff (PDF)

Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules

Biochemistry (Easton), 1989-02, Vol.28 (4), p.1737-1743

1989

Volltextzugriff (PDF)

Inhibition of tumor metastasis by heparanase inhibiting species of heparin

Invasion and metastasis, 1994, Vol.14 (1-6), p.290

1994

Volltextzugriff (PDF)

Bleeding times in rats treated with heparin, heparin fragments of high and low anticoagulant activity and chemically modified heparin fragments of low anticoagulant activity

Thrombosis and haemostasis, 1990-08, Vol.64 (1), p.127-132

1990

Volltextzugriff (PDF)

Synthesis of the methyl glycosides of a tri- and a tetra-saccharide related to heparin and heparan sulphate

Carbohydrate research, 1993-08, Vol.246 (1), p.161-172

1993

Volltextzugriff (PDF)

Inhibition of angiogenesis by heparin fragments in the presence of hydrocortisone

Carbohydrate polymers, 1992, Vol.18 (1), p.9-16

1992

Volltextzugriff (PDF)

Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix

Biochemistry (Easton), 1992-02, Vol.31 (7), p.2080-2088

1992

Volltextzugriff (PDF)

Tranexamic acid derivatives with enhanced absorption

Journal of medicinal chemistry, 1986-04, Vol.29 (4), p.448-453

1986

Volltextzugriff (PDF)

Characterization of the Heparin-Mediated Activation of PKR, the Interferon-Inducible RNA-Dependent Protein Kinase

Virology (New York, N.Y.), 1996-07, Vol.221 (1), p.180-188

1996

Volltextzugriff (PDF)

Low-sulphated oligosaccharides derived from heparan sulphate inhibit normal angiogenesis

Glycobiology (Oxford), 1993-12, Vol.3 (6), p.567-573

1993

Volltextzugriff (PDF)

Vascular endothelial growth factor is inactivated by binding to α2-macroglobulin and the binding is inhibited by heparin

The Journal of biological chemistry, 1993-04, Vol.268 (11), p.7685-7691

1993

Volltextzugriff (PDF)

Variations in the Size and Sulfation of Heparin Modulate the Effect of Heparin on the Binding of VEGF165 to Its Receptors

Biochemical and biophysical research communications, 1994-09, Vol.203 (2), p.1339-1347

1994

Volltextzugriff (PDF)

Inhibition of smooth muscle cell proliferation and neointimal growth by low-anticoagulant heparin

Arzneimittel-Forschung, 1995-05, Vol.45 (5), p.546

1995

Volltextzugriff (PDF)

Absorption of tranexamic acid as a prodrug in healthy volunteers

Arzneimittel-Forschung, 1988-05, Vol.38 (5), p.735

1988

Volltextzugriff (PDF)

Modulation of neovascularization and metastasis by species of heparin

Advances in experimental medicine and biology, 1992, Vol.313, p.317

1992

Volltextzugriff (PDF)

Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin

Israel journal of medical sciences, 1995-02, Vol.31 (2-3), p.106

1995

Volltextzugriff (PDF)

Dicarboxidine [γ,γ′-(4,4′-diamino-3,3′-biphenylylenedioxy)dibutyric acid] dihydrochloride as a chromogen for the detection of barbiturates, meprobamate and some other sedatives on thin-layer chromatograms

Journal of Chromatography A, 1979-02, Vol.170 (1), p.294-295

1979

Volltextzugriff (PDF)

Electron capture gas chromatography of tertiary amines as pentafluorobenzyl carbamates

Analytical chemistry (Washington), 1976-02, Vol.48 (2), p.390-393

1976

Volltextzugriff (PDF)

Synthesis of tri- and tetrasaccharides present in the linkage region of heparin and heparin sulphate

Journal of carbohydrate chemistry, 1993, Vol.12 (1), p.23-37

1993

Volltextzugriff (PDF)

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(133)
Tagungsberichte
(4)

Sprache

Englisch
(126)
Französisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Structure of a heparin-linked biologically active dimer of fibroblast growth factor

FGF Binding and FGF Receptor Activation by Synthetic Heparan-Derived Di- and Trisaccharides

Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells

Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin

Differential effect of cell-associated heparan sulfates on the binding of keratinocyte growth factor (KGF) and acidic fibroblast growth factor to the KGF receptor

Inhibition of antigen-induced acute bronchoconstriction, airway hyperresponsiveness, and mast cell degranulation by a nonanticoagulant heparin : Comparison with a low molecular weight heparin

Importance of Size, Sulfation, and Anticoagulant Activity in the Potentiation of Acidic Fibroblast Growth Factor by Heparin

Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules

Inhibition of tumor metastasis by heparanase inhibiting species of heparin

Bleeding times in rats treated with heparin, heparin fragments of high and low anticoagulant activity and chemically modified heparin fragments of low anticoagulant activity

Synthesis of the methyl glycosides of a tri- and a tetra-saccharide related to heparin and heparan sulphate

Inhibition of angiogenesis by heparin fragments in the presence of hydrocortisone

Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix

Tranexamic acid derivatives with enhanced absorption

Characterization of the Heparin-Mediated Activation of PKR, the Interferon-Inducible RNA-Dependent Protein Kinase

Low-sulphated oligosaccharides derived from heparan sulphate inhibit normal angiogenesis

Vascular endothelial growth factor is inactivated by binding to α2-macroglobulin and the binding is inhibited by heparin

Variations in the Size and Sulfation of Heparin Modulate the Effect of Heparin on the Binding of VEGF165 to Its Receptors

Inhibition of smooth muscle cell proliferation and neointimal growth by low-anticoagulant heparin

Absorption of tranexamic acid as a prodrug in healthy volunteers

Modulation of neovascularization and metastasis by species of heparin

Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin

Dicarboxidine [γ,γ′-(4,4′-diamino-3,3′-biphenylylenedioxy)dibutyric acid] dihydrochloride as a chromogen for the detection of barbiturates, meprobamate and some other sedatives on thin-layer chromatograms

Electron capture gas chromatography of tertiary amines as pentafluorobenzyl carbamates

Synthesis of tri- and tetrasaccharides present in the linkage region of heparin and heparin sulphate

Suchergebnisse filtern